MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene Expression Profiles: An Adaptable Registry (FLEX Registry),

Description

Sponsor: Agendia
Role: Site Co-PI: Responsible for educating the patients about the study, coordinating the study as part of multi-center study.
Goal: Assess the clinical and genomic profile or patients with breast cancer stage 1-3

Period	2023 → …